BE881208A - Composition pharmaceutique pour le traitement de psoriasis et methode d'utilisation de celle-ci - Google Patents
Composition pharmaceutique pour le traitement de psoriasis et methode d'utilisation de celle-ciInfo
- Publication number
- BE881208A BE881208A BE0/199011A BE199011A BE881208A BE 881208 A BE881208 A BE 881208A BE 0/199011 A BE0/199011 A BE 0/199011A BE 199011 A BE199011 A BE 199011A BE 881208 A BE881208 A BE 881208A
- Authority
- BE
- Belgium
- Prior art keywords
- psoriasis
- treatment
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/08—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81476577A | 1977-07-11 | 1977-07-11 | |
US2875879A | 1979-04-10 | 1979-04-10 | |
US2875779A | 1979-04-10 | 1979-04-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
BE881208A true BE881208A (fr) | 1980-05-16 |
Family
ID=27363337
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE189191A BE868882A (fr) | 1977-07-11 | 1978-07-10 | Derives halogenomethyles d'alpha-aminoacides, leur preparation et leurs utilisations therapeutiques |
BE0/199012A BE881209A (fr) | 1977-07-11 | 1980-01-17 | Composition pharmaceutique pour lutter contre le taux de croissance des tumeurs et methode d'utilisation de celle-ci |
BE0/199011A BE881208A (fr) | 1977-07-11 | 1980-01-17 | Composition pharmaceutique pour le traitement de psoriasis et methode d'utilisation de celle-ci |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE189191A BE868882A (fr) | 1977-07-11 | 1978-07-10 | Derives halogenomethyles d'alpha-aminoacides, leur preparation et leurs utilisations therapeutiques |
BE0/199012A BE881209A (fr) | 1977-07-11 | 1980-01-17 | Composition pharmaceutique pour lutter contre le taux de croissance des tumeurs et methode d'utilisation de celle-ci |
Country Status (9)
Country | Link |
---|---|
JP (1) | JPS5419913A (fr) |
AU (1) | AU522660B2 (fr) |
BE (3) | BE868882A (fr) |
CA (1) | CA1091661A (fr) |
CH (1) | CH642055A5 (fr) |
DE (1) | DE2828739A1 (fr) |
FR (1) | FR2430418A1 (fr) |
GB (1) | GB2001960B (fr) |
NL (2) | NL190662C (fr) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0228034A3 (en) * | 1985-12-19 | 1990-05-09 | Merrell Dow Pharmaceuticals Inc. | Arginine and agmatine derivatives for treating protozoal infections |
US6103220A (en) * | 1998-01-23 | 2000-08-15 | Levine; Martin | Lysine decarboxylase inhibitors for the prevention and treatment of periodontal disease |
US6187296B1 (en) | 1998-01-23 | 2001-02-13 | The Board Of Regents Of The University Of Oklahoma | Lysine decarboxylase inhibitors for the prevention and treatment of periodontal disease |
WO2004087083A3 (fr) * | 2003-03-26 | 2005-05-26 | Gillette Co | Ralentissement de la pousse des poils |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PH16634A (en) * | 1980-06-16 | 1983-12-05 | Merrell Dow Pharma | Method of inhibiting the growth of protozoa |
US4399151A (en) | 1980-06-16 | 1983-08-16 | Merrell Dow Pharmaceuticals Inc. | Method of inhibiting the growth of protozoa |
GB2083030B (en) * | 1980-08-23 | 1984-03-07 | Merrell Toraude & Co | Fluorinated pentene diamine derivatives |
ZA815808B (en) * | 1980-08-23 | 1982-08-25 | Merrell Toraude & Co | Fluorinated pentene diamine derivatives |
US4437873A (en) | 1981-03-23 | 1984-03-20 | Merrell Dow Pharmaceuticals Inc. | Method of inhibiting algae |
US4446151A (en) * | 1981-08-19 | 1984-05-01 | Merrell Toraude Et Compagnie | Decarboxylase-inhibiting fluorinated pentane diamine derivatives |
US4423073A (en) * | 1981-08-19 | 1983-12-27 | Merrell Toraude Et Compagnie | Fluorinated diaminopentene derivatives |
US4435425A (en) | 1982-04-09 | 1984-03-06 | Merrell Toraude Et Compagnie | Fluorinated diaminobutane derivatives |
EP0326766B1 (fr) * | 1988-02-05 | 1992-06-17 | Merrell Dow Pharmaceuticals Inc. | Dérivés 5-substitués d'ornithine |
CA1319123C (fr) * | 1988-08-31 | 1993-06-15 | Andrew T. Au | Methode de preparation de (-)-derives de substitution en 2 d'ornithines |
WO2021209563A1 (fr) | 2020-04-16 | 2021-10-21 | Som Innovation Biotech, S.A. | Composés destinés à être utilisés dans le traitement d'infections virales par un coronavirus associé au syndrome respiratoire |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ187377A (en) * | 1977-06-01 | 1981-05-15 | Merck & Co Inc | A-amino-a-substituted alkyl-a-fluoromethylacetic acids |
-
1978
- 1978-06-07 CA CA304,918A patent/CA1091661A/fr not_active Expired
- 1978-06-21 AU AU37327/78A patent/AU522660B2/en not_active Expired
- 1978-06-27 GB GB7827967A patent/GB2001960B/en not_active Expired
- 1978-06-30 DE DE19782828739 patent/DE2828739A1/de active Granted
- 1978-07-10 BE BE189191A patent/BE868882A/fr not_active IP Right Cessation
- 1978-07-10 FR FR7820517A patent/FR2430418A1/fr active Granted
- 1978-07-10 CH CH746678A patent/CH642055A5/de not_active IP Right Cessation
- 1978-07-11 JP JP8361978A patent/JPS5419913A/ja active Granted
- 1978-07-11 NL NL7807453A patent/NL190662C/xx not_active IP Right Cessation
-
1980
- 1980-01-17 BE BE0/199012A patent/BE881209A/fr not_active IP Right Cessation
- 1980-01-17 BE BE0/199011A patent/BE881208A/fr not_active IP Right Cessation
-
1995
- 1995-11-17 NL NL950027C patent/NL950027I2/nl unknown
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0228034A3 (en) * | 1985-12-19 | 1990-05-09 | Merrell Dow Pharmaceuticals Inc. | Arginine and agmatine derivatives for treating protozoal infections |
US6103220A (en) * | 1998-01-23 | 2000-08-15 | Levine; Martin | Lysine decarboxylase inhibitors for the prevention and treatment of periodontal disease |
US6187296B1 (en) | 1998-01-23 | 2001-02-13 | The Board Of Regents Of The University Of Oklahoma | Lysine decarboxylase inhibitors for the prevention and treatment of periodontal disease |
WO2004087083A3 (fr) * | 2003-03-26 | 2005-05-26 | Gillette Co | Ralentissement de la pousse des poils |
US7015349B2 (en) | 2003-03-26 | 2006-03-21 | The Gillette Company | Reduction of hair growth |
US7345192B2 (en) | 2003-03-26 | 2008-03-18 | The Gillette Company | Reduction of hair growth |
Also Published As
Publication number | Publication date |
---|---|
NL7807453A (nl) | 1979-01-15 |
CH642055A5 (de) | 1984-03-30 |
CA1091661A (fr) | 1980-12-16 |
AU522660B2 (en) | 1982-06-17 |
AU3732778A (en) | 1980-01-03 |
GB2001960B (en) | 1982-02-24 |
JPS5419913A (en) | 1979-02-15 |
FR2430418A1 (fr) | 1980-02-01 |
NL190662B (nl) | 1994-01-17 |
GB2001960A (en) | 1979-02-14 |
NL950027I1 (nl) | 1996-02-01 |
FR2430418B1 (fr) | 1984-07-13 |
NL190662C (nl) | 1994-06-16 |
NL950027I2 (nl) | 1997-06-02 |
BE881209A (fr) | 1980-05-16 |
BE868882A (fr) | 1978-11-03 |
JPH0122259B2 (fr) | 1989-04-25 |
DE2828739A1 (de) | 1979-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE851328A (fr) | Composition pour le traitement de l'hypercholesterolemie | |
BE884917A (fr) | Agent pour le traitement de theilerioses et son application | |
BE870055A (fr) | Compositions et procede pour le traitement des calculs renaux | |
BE880905A (fr) | Compositions influencant le systeme nerveux central et leur methode d'utilisation | |
BE881208A (fr) | Composition pharmaceutique pour le traitement de psoriasis et methode d'utilisation de celle-ci | |
BE876157Q (fr) | Medicament pour le traitement de l'acne | |
BE868544A (fr) | Composition contenant du dithranol pour le traitement du psoriasis | |
BE852095A (fr) | Composition pharmaceutique pour le traitement de la leucemie et de tumeurs | |
BE829859A (fr) | Procedes et compositions pharmaceutiques pour le traitement de l'hypercholesterolemie | |
FR2277591A1 (fr) | Composition pharmaceutique pour la prevention et le traitement de l'alcoolisme | |
BE885290A (fr) | Compositions pharmaceutiques pour le traitement des hyperlipidemies et des hyperlipoproteinemies | |
FR2558372B1 (fr) | Composition medicamenteuse pour le traitement de l'acne | |
BE871753A (fr) | Nouvelle utilisation therapeutique de l'acetyl-1-carnitine pour le traitement des affections cardiaques | |
BE856740A (fr) | Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire | |
BE856957A (fr) | Electrode pour traitement d'ionophorese | |
FR2340737A1 (fr) | Composition pour le traitement de l'hypercholesterolemie | |
FR2433978B1 (fr) | Traitement d'algues | |
FR2546530B1 (fr) | Traitement de laitiers d'acierie en vue de leur utilisation en cimenterie | |
BE894228A (fr) | Composition pharmaceutique pour le traitement de l'atherosclerose | |
RO88351A3 (fr) | Composition pour le traitement des affections gastroduodenales | |
BE842389A (fr) | Composition pharmaceutique pour le traitement de l'hyperuricemie | |
RO65965A2 (fr) | Composition medicamenteuse pour le traitement d'ulcere gastroduodenel | |
FR2562798B1 (fr) | Agent pharmaceutique pour le traitement du psoriasis | |
RO79428A2 (fr) | Composition medicamenteuse pour le traitement des dermatoses | |
BE869248A (fr) | Compositions pharmaceutiques pour le traitement de l'hyperglucagonemie et/ou de l'hyperglycemie |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE20 | Patent expired |
Owner name: MERREL TORAUDE ET CIE Effective date: 20000117 |